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Introduction
The assembly pathway of many double strand DNA containing viruses, including the lambdoid phage, herpesviruses and adenoviruses proceeds through the formation of a precursor particle called a prohead or procapsid (Prevelige and Fane, 2012) (Fig. 1A) . The procapsid is composed of icosahedrally disposed coat protein subunits surrounding an interior volume containing scaffolding protein rather than nucleic acid. In a subsequent packaging step, the scaffolding protein is removed either by proteolysis or direct exit, and the DNA is packaged into the protein shell through the action of a multi-protein molecular motor. One component of the motor complex, termed the portal or connector protein, is a fixed dodecamer located at one of the 5-fold vertices of the icosahedron (reviewed in Bazinet and King (1985) . Other elements of the motor complex are referred to as terminase components. These proteins specifically recognize the viral DNA, deliver it to the connector complex, and convert chemical energy in the form of ATP into the mechanical energy required for DNA packaging (reviewed in Black (1989) .
The procapsid contains a single connector complex, which replaces the coat protein subunits at one of the twelve 5-fold vertices (Chang et al., 2006; Tang et al., 2011; Tao et al., 1998) . There is genetic and biochemical evidence for an interaction of the connector protein with the scaffolding protein in a number of dsDNA containing viruses including: herpes simplex (Singer et al., 2005; Yang et al., 2013) , P22 (Greene and King, 1996; Weigele et al., 2005) , T4 (Laemmli et al., 1970; Mesyanzhinov et al., 1990) , and lambda (Murialdo, 1979; Murialdo and Becker, 1978a) . However, the mechanism by which a single vertex is differentiated from the other eleven during assembly has remains obscure. Models in which it is incorporated as the first step of assembly or as the final step of assembly have been proposed (Bazinet et al., 1990; Cerritelli and Studier, 1996; Moore and Prevelige, 2002; Murialdo and Becker, 1978b) . However, recent experimental evidence favors the notion that connector incorporation occurs early during assembly and is perhaps involved in nucleation (Fu and Prevelige, 2009; Fu et al., 2010) .
In the case of the prolate dsDNA containing Bacillus subtilis bacteriophage ϕ29, the connector complex occupies one of the two 5-fold vertices lying on the long axis of the 43 nm Â 53 nm procapsid (Tao et al., 1998) . The procapsid itself consists of 235 copies of the coat protein and approximately 180 copies of the internal form determining scaffolding protein (Guo et al., 1987; Peterson et al., 2001; Tao et al., 1998) . Fifty-five head fiber proteins are bound to the local three-fold positions and thereby decorate the procapsid (Tao et al., 1998; Xiang and Rossmann, 2011) .
DNA packaging results in exit of the scaffolding protein, and the attachment of the tail protein at the portal vertex (reviewed by (King et al., 1976) . Although the crystal structure of the 50 kDa ϕ29 coat protein has not been solved, cryo-electron microscopy reconstructions demonstrate that the protein assumes the prevalent HK97 fold (Morais et al., 2005) . In contrast, crystal structures of the recombinantly-expressed 11 kDa scaffolding and 35 kDa connector proteins are available (Guasch et al., 2002; Morais et al., 2003; Simpson et al., 2000) . The scaffolding protein consists of three α-helices; the N-terminus displays a helix-loop-helix motif, while the C-terminus is disordered. Successive deletions of the scaffolding protein C-terminus revealed its likely participation in (Fu et al., 2010 ). In the model, a total of six scaffolding protein dimers interact with a connector dodecamer. They are situated at the interface between every other connector subunit with their N-terminal helix-loop-helix motif pointed towards the interior of the capsid. (C) The proposed electrostatic interactions of the scaffolding dimer (green) between two connector (gold) subunits. The scaffolding protein amino acids R69 and E56 are hypothesized to interact with E114 and R110 of the connector, respectively.
binding to the coat protein during morphogenesis . The structure of the connector protein consists of three centrally located α-helices separating the wide and narrow β-sheet-rich domains. The dodecamer is arranged as a 75 Å-long "flower pot"-shaped structure. The 69 Å diameter wide end of the dodecamer occupies the internal region of the procapsid, whereas the 33 Å diameter narrow end extends outward to make external contacts with the other components of the motor complex (Fig. 1B) .
In vitro assembly studies using purified proteins suggest that a complex of the connector and scaffolding proteins serves to nucleate assembly (Fu and Prevelige, 2009 ). Computational docking studies using the available crystal structures and distance constraints derived from chemical crosslinking experiments were previously employed to develop a model for scaffolding-connector protein interactions (Fu et al., 2010) (Fig. 1C) . Models of the molecular basis of recognition between proteins can be tested through the introduction and evaluation of site-specific mutations at the presumptive interface. For instance, the proposed docking model was used as a guide to introduce a lysine residue into the scaffold protein, which resulted in a new lysine-to-lysine crosslink between the scaffolding and connector proteins in vitro. Based on the mutagenesis and crosslinking studies a domain model for the scaffolding protein was proposed in which the C-terminal unstructured residues bind to and recruit the coat protein subunits, while the upstream region (residues 65 to 74) dock with the connector protein to ensure its incorporation (Fu et al., , 2010 .
It is desirable to have a facile mechanism to test the role of scaffolding mutations in vivo. Trans-complementation systems in which the mutant protein can be expressed from a plasmid and experimentally tested for its ability to complement a defective virus provide such an approach. In this manuscript we report the development of a trans-complementation system for the bacteriophage ϕ29 scaffolding protein and its use to test the previously proposed scaffolding-connector protein docking model.
Results

In vitro analysis of scaffolding/coat protein interactions
The docking model predicts that interactions between the scaffold and connector proteins are mediated at least in part by electrostatic interactions (Fu et al., 2010) . To test this hypothesis, point mutations predicted to weaken scaffolding-connector protein interactions, either through the loss of charge/charge attractions (K66A) or the introduction of charge/charge repulsion (E56K, R69E), were engineered into a cloned ϕ29 wild type scaffolding gene (gp7). These mutations are thought to lie in the connector binding domain and not expected to affect procapsid assembly in the absence of the connector protein. To ensure that the mutant proteins retained function, each protein was purified and tested for its ability to promote the assembly of procapsid-like particles in vitro.
Under standard in vitro assembly conditions the coat protein self-associates into aberrant structures in the absence of wild type scaffolding protein. However, upon the addition of wild type scaffolding protein, procapsid-like particles are produced . While both aggregation and controlled assembly of the coat protein result in a time-dependent increase in turbidity, the kinetics and extent of the increase are typically distinct. Controlled assembly displays a hyperbolic-shaped progress curve that levels off after approximately ten minutes, whereas uncontrolled coat protein assembly increases linearly throughout the duration of the experiment (Fig. 2) . The assembly kinetics with the three mutant proteins (E56K, K66A, and R69E) all follow a trajectory similar to that obtained with the wild type scaffolding protein. The rate of assembly and final degree of turbidity suggest the mutant proteins are as efficient as wild type protein in directing assembly in vitro.
To characterize the products of each reaction, the rapidly sedimenting species were isolated from the monomeric reactants by sucrose gradient centrifugation and subsequently visualized by negative stain electron microscopy. The presence of procapsid-like particles with morphologies similar to those obtained in the wild type scaffolding reaction was confirmed for each of the mutant scaffolding proteins (data not shown). These experiments suggest that the introduced point mutations have little effect on the ability of the scaffolding protein to interact with coat protein and promote particle assembly.
Analysis of scaffolding-connector protein interactions
To determine whether the scaffolding mutants could interact with the connector in vitro we employed a previously described assay for scaffolding-connector interactions. This assay is based on the ability of the scaffolding protein to solubilize the connector dodecamer at low ionic strength (Fu and Prevelige, 2009) . At low ionic strength, in the absence of wild type scaffolding protein, the connector protein (gp10) aggregates and is readily removed from solution by centrifugation (Fig. 3 , lane 2). The inclusion of wild type scaffolding protein (gp7) restores connector solubility in a concentration dependent fashion. SDS-PAGE analysis of the supernatant following centrifugation provides a semi-quantitative measure of solublization (Fig. 3, lanes 3 and 4) . When compared to the wild type scaffolding protein all of the mutant scaffolding proteins display an abolished ability to solubilize the connector protein even at the highest concentration (Fig. 3 , lanes 5-10) suggesting that these charge change alterations negatively affect the binding of the mutant scaffolding proteins to the connector dodecamer.
Analysis of the effect of scaffolding mutations on virus production
While the in vitro studies support the notion that defined scaffolding protein mutations can disrupt scaffolding-connector protein interactions, they are incapable of directly evaluating the effect of the mutations on virus production. Introducing specific point mutations into the 45 kbp ϕ29 genome is technically demanding and precludes the analysis of potentially lethal mutations. To facilitate these sorts of investigations, an in vivo transcomplementation system was developed. Briefly, the ϕ29 scaffolding gene was cloned into the shuttle vector pHCM05, which carries both the E. coli and B. subtilis origins of replication, an IPTG inducible promoter, and both ampicillin and chloramphenicol resistance markers (Nguyen et al., 2005) . The desired mutations were introduced by site-directed mutagenesis, verified by sequencing, and the plasmids were transformed into B. subtilis protoplasts. IPTG-driven gene induction resulted in approximately tenfold over-expression of wild type or mutant scaffolding gene as analyzed by Western blotting (data not shown).
To determine if the wild type and mutant scaffolding proteins were capable of supporting phage replication the trans-complementation tested by a direct plaque assay. A strain of ϕ29 carrying an amber mutation at the N-terminus of the scaffolding gene (amber-gp7) was plated on lawns of B. subtilis spoA12 su À cells harboring plasmids expressing wild type or mutant scaffolding genes and the number of plaques counted. The strain expressing the wild type scaffolding gene complemented the amber-gp7 strain and resulted in titers comparable to those obtained when the amber mutation is suppressed using a su +44 strain of B. subtilis (Fig. 4) . In contrast, the charge reversal mutants E56K and R69E were defective in their ability to complement the amber-gp7 strain, as titers were only slightly above background. The K66A mutant protein complemented with a plating efficiency comparable to that obtained with the wild type scaffolding protein; however, the plaque sizes were noticeably smaller. These data indicate that the K66A mutant scaffolding protein can support progeny production at the level of plaque formation, but there is likely a functional defect.
Analysis of the kinetics of complementation
To further characterize the trans-complementation system the kinetics of virus replication was compared to the replication kinetics of a wild type infection at low multiplicity of infection. Infections were performed with wild type ϕ29 in non-suppressor spoA12 su À B. subtilis cells, the amber-gp7 strain in suppressor su +44 cells, and the amber-gp7 strain in the trans-complementation system using both the wild type and the K66A mutant scaffolding proteins synthesized in spoA12 su À cells (Fig. 5) . The wild type ϕ29 infection in su À cells and the amber-gp7 infection in su +44 cells both display a 40 min lag phase; the rate of progeny production and final virion yield are nearly identical. The amber-gp7 infection in cells expressing the wild type scaffolding protein exhibited an extended lag phase with a further delay of approximately 20 min in the onset of exponential phase. However, the final yield was comparable to the control infections. In contrast, the rate of phage production upon trans-complementation with the K66A scaffolding protein displayed a 40 min delay in the onset of exponential phase and a greater than ten-fold decrease in final yield relative to the control infections. This result is consistent with the smaller plaque sizes observed in the complementation analyses.
Mechanistic analysis of the defective scaffolding proteins
Mutations in the scaffolding gene were designed to test the scaffolding-connector docking model by specifically disrupting scaffolding-connector protein interactions without otherwise interfering with scaffolding protein function in assembly. Thus, it was hypothesized that expression of the mutant genes would result in the production of procapsid-like particles that lack the connector dodecamer and therefore cannot mature into virion. As expected, each of the mutant scaffolding proteins displayed a severely diminished ability to properly complement the amber-gp7 strain and produce phage. To determine if procapsids or procapsid-like particles formed, cells were lysed two-hours after a amber-gp7 phage infection and scaffolding gene induction. The lysates were clarified and the proteins, procapsids, and phage were separated by sucrose gradient centrifugation as described in Materials and Methods. Following centrifugation, each gradient was separated into approximately 40 fractions. The protein composition of each fraction was analyzed by Western Blot using antibodies that recognize coat and head fiber proteins (Fig. 6 , top panel A-F) or connector protein (Fig. 6, bottom panel A-F) .
The amber-gp7 infection in su +44 cells (Fig. 6 , top panel A) or in spoA12 su À cells expressing wild type scaffolding protein (Fig. 6 , top panel B) displayed coat and head fiber proteins throughout the entire gradient, with peak intensities present in fractions 5-9 and 15-21. Titering each fraction demonstrated that virions sediment to fractions 5-9. Electron microscopy of fractions 15-21 identified these as the procapsid containing fractions. Western Blots using the anti-connector antibody (lower panels) displayed peaks of connector protein in the same fractions suggesting that the connector was incorporated into both procapsids and virions. As expected, amber-gp7 infections in spoA12 su À cells not harboring a plasmid to express scaffolding protein do not yield virions. Fig. 6F (top panel), indicates that the coat protein can be detected throughout the gradient consistent with mixed populations of unassembled protein and aberrant particles. The bottom panel demonstrates that in the absence of scaffolding protein the connector is not incorporated and remains toward the top of the gradient (fractions 23-27).
As can be seen in Fig. 6C -E, the mutant scaffolding proteins display three different phenotypes. The K66A scaffolding protein, which weakly complements the amber-gp7 strain shows the presence of capsid and connector proteins in fractions 5-7 consistent with virion production. However, the majority of the coat, head fiber and connector proteins sediment to the region corresponding to procapsids at the top of the gradient, indicating a moderate defect in connector incorporation and/or conversion to infectious virions (Fig. 6C) . Surprisingly, the E56K scaffolding protein appears to form procapsids, which have incorporated the connector but fail to yield infectious virions (Fig. 6D) , suggesting an alternative phenotypic defect such as a packaging error or the formation of aberrant particles. Lastly, the R69E scaffolding protein fails to incorporate the connector and is also defective in producing procapsids or infectious phage (Fig. 6E) .
Morphological characterization of the purified particles produced during each infection was performed using electron microscopy ( Fig. 7A-C Scaffold (gp7) Fig. 3 . In vitro identification of connector and scaffolding binding residues. The ability of wild type or mutant scaffolding proteins to solubilize the connector protein (16 mM) at low ionic strength was determined by measuring the amount of connector in the supernatant following centrifugation. Lane 1: Molecular weight marker; Lane 2: connector protein only; Lanes 3 and 4: connector plus WT scaffolding protein at 3-fold and 6-fold molar excess, respectively; Lanes 5 and 6: connector plus E56K scaffolding protein at 3-fold and 6-fold molar excess, respectively; Lanes 7 and 8: connector plus K66A scaffolding protein at 3-fold. and 6-fold molar excess, respectively; Lanes 9 and 10: connector plus R69E. scaffolding protein at 3-fold and 6-fold molar excess, respectively.
with a morphology typical of ϕ29 virion (Fig. 7A) . Particles acquired from the amber-gp7 infection in cells expressing the E56K mutant scaffolding protein are non-infectious with mixed morphologies (Fig. 7B ) with a population of these particles display a prolate nature. However, the particles isolated from the ambergp7 infection in cells expressing the R69E scaffolding protein are isometric (Fig. 7C) , a characteristic consistent with a failure to incorporate the dodecameric connector complex (Choi et al., 2006; Hagen et al., 1976) .
Discussion
The assembly of many dsDNA containing bacteriophage proceeds through the formation of a precursor particle called a prohead or procapsid. The B. subtilis bacteriophage ϕ29 procapsid is composed of 235 copies of the coat protein, approximately 180 copies of the scaffolding protein and a single dodecamer of connector protein located at a five-fold vertex (Guo et al., 1987; Peterson et al., 2001; Tao et al., 1998) . Previous in vitro assembly experiments using purified ϕ29 coat, scaffold, and connector proteins suggest that the mechanism guiding the incorporation of a single dodecamer per procapsid involves the formation of a nucleation complex between the scaffolding and connector proteins (Fu and Prevelige, 2009; Fu et al., 2010) . Based upon the available crystal structures, distance constraints derived from chemical crosslinking experiments and computational docking studies, a domain model for scaffoldingconnector protein interactions was developed. This model proposed that the C-terminal unstructured residues of the scaffolding protein bind to and recruit the coat protein subunits, while the upstream region (residues 65 to 74) dock with the connector dodecameric protein to ensure its incorporation (Fu et al., , 2010 .
The domain model identifies particular amino acid residues that may form electrostatic interactions between the scaffolding and connector proteins. To determine whether charge change amino acid substitutions would affect binding between the two proteins, mutant scaffolding genes were cloned, expressed and assayed for the ability to promote particle assembly and bind to the wild type connector protein in vitro. Results from this analysis indicate that the introduced mutations do not affect the ability of the scaffolding protein to bind the coat proteins and promote procapsid-like particle assembly, suggesting that the purified proteins retain a wild type scaffolding protein fold. However, in vitro solubilization experiments with purified scaffolding and connector proteins indicate that the charge change mutants abolish the interaction between the scaffolding and connector proteins.
To determine if the scaffolding protein residues identified in the domain docking model participate in connector binding in vivo, a trans-complementation system was developed. In direct plating assays the wild type scaffolding effectively complemented a amber-gp7 ϕ29. A lysine to alanine substitution was functional though less efficient whereas two charge reversal mutations failed to complement the amber-gp7 strain at all.
In an effort to further characterize the developed complementation system, a kinetic analysis was performed using a wild type ϕ29 strain and the amber-gp7 strain. As controls, a B. subtilis spoA12 su À cell line was infected with the wild type strain, and a su 44+ cell line was infected with the amber-gp7 strain. The kinetics of virion production was also analyzed in spoA12 su À cells harboring plasmids induced to express the wild type and K66A scaffolding proteins. Upon infection, complementation with the wild type scaffolding protein displayed a slight delay in the onset of the exponential phase but obtained a final progeny yield as the control infection. In contrast, expression of the K66A protein demonstrated a significant forty minute delay before reaching exponential phase and a ten-fold decrease in virion yield after two hours. This result is consistent with the previous published in vitro analysis indicating that the connector forms a nucleation complex with the scaffolding protein to promote virus assembly (Fu and Prevelige, 2009) . Biochemical analyses of the particles generated in cells expressing the wild type and mutant scaffolding proteins to complement the amber-gp7 strain indicate the possibility of three different assembly defects. As expected, complementation with the wild type protein resulted in the formation of infectious virion. The weakly complementing K66A protein resulted in some virion production, but a majority of the structural proteins sedimented to a region corresponding to procapsids suggesting a primary defect in a conversion to infectious virion. The E56K scaffolding protein demonstrated connector incorporation; however assembled particles were distributed throughout the gradient, indicating a range of aberrant particles and possibly a connector that is situated in a manner that affects DNA packaging. Lastly, the R69E scaffolding protein failed to incorporate the connector, as the connector protein was only present in the late fractions of the sucrose gradient. In addition, micrographs of particles generated in cells expressing the R69E protein display an isometric appearance, an observation also consistent with a failure to incorporate the connector. Taken together these experiments support the model that connector incorporation in vivo is coupled to scaffolding docking and provide validation for the specific docking model previously proposed. The delay in replication seen with the K66A mutant coupled with its decreased yield of infectious phage provides circumstantial evidence that the formation of a stable connector-scaffold complex is coupled to nucleation of assembly. Finally, the development of a facile shuttle vector based trans-complementation system makes it much simpler to investigate the role of particular scaffolding protein residues in ϕ29 replication.
Materials and methods
Plasmid construction
To express and purify protein, the mutant scaffolding genes (E56K, R69E and K66A) were constructed from the pET3c-gp7 plasmid by QuickChange s Site-Directed Mutagenesis Kit (Stratagene) using the primers (5′-CTCATGAAAAGTTAGCCGCTAAAAAAGATGATCT-GATCGTG-3′), (5′-GATCGTGTCAAATAGTAAGCTTTTCGAACAGATTGG TTTGACAGACAAACAG-3′) and (5′-GATGATCTGATCGTGTCAAATAGTG CGCTTTTCAGACAGATTG-3′), respectively. The resulting plasmids, pET3c-gp7-E56K, pET3c-gp7-R69E and pET3c-gp7-K66A, were transformed into Escherichia coli BL21 (DE3) cells. For in vivo complementation, the ϕ29 wild type and mutant scaffolding coding sequences were amplified by PCR from plasmids pET3c-gp7, pET3c-gp7-E56K, pET3c-gp7-R69E and pET3c-gp7-K66A and digested at the primer-encoded BamHI and XbaI sites, then ligated into the similarly digested shuttle vector pHCMC05 (from Bacillus Genetic stock center). The ligation products were transformed into E. coli DH5α cells to obtain the plasmids, pHCMC05-wt-gp7, pHCMC05-gp7-E56K, pHCMC05-gp7-R69E and pHCMC05-gp7-K66A, which were transformed into the B. subtilis spoA12 su À cells by protoplast transformation (Chang and Cohen, 1979) .
Protein preparation
The ϕ29 wild type and mutant scaffolding proteins were synthesized in E. coli BL21 (DE3) cells harboring plasmids pET3c-gp7-E56K, pET3c-gp7-R69E and pET3c-gp7-K66A through IPTG induction (1 mM). Following cell lysis and clarification, the mutant proteins were purified by ammonium sulfate precipitation (S 40 ) and HI-trap Q HP column using a NaCl gradient. The scaffolding protein eluted at 180 mM NaCl in 50 mM Tris-HCl (pH 8.0) and 1 mM EDTA, and then dialyzed against TMS buffer (50 mM Tris, pH 7.8, 10 mM MgCl 2 , and 100 mM) for storage.
The ϕ29 connector protein was synthesized in E. coli BL21 (DE3) cells carrying the pPLc28D plasmid and was purified by Hi-Trap SP HP column and HI-trap Q HP column as described (Fu and Prevelige, 2009; Poliakov et al., 2007) .
The ϕ29 coat protein was initially purified from inclusion bodies and refolded at 1 mg/ml in 0.7 M arginine at pH 8.0. The refolded coat protein bound to a HI-trap Q HP column and eluted at 150 mM NaCl in the buffer of 100 mM Tris (pH 8.0) and 10 mM MgCl 2 as described previously .
In vitro assembly reactions
The reactions were performed as previously described . Briefly, a 21% PEG-3350, 100 mM Tris (pH 8.0) and 10 mM MgCl 2 buffer was equilibrated to 13 1C. A mixture of 20 mM coat protein and 40 mM scaffolding mutant protein was used to obtain a final buffer of 6%PEG, 60 mM NaCl, 100 mM Tris (pH 8.0) and 10 mM MgCl 2 . Assembly kinetics were monitored at 340 nm over a 2 h period.
In vitro solubilization assay
The assay was performed as described previously with some modifications (Fu and Prevelige, 2009) . Purified connector protein (16 μM) was mixed with scaffolding protein at 3 and 6-fold molar excess. The mixture was dialyzed against 89 mM Tris-borate (pH 8.3) and 2.5 mM EDTA buffer for 30 min at room temperature and transferred to TMS buffer for 1 h at room temperature. The samples were subjected to centrifugation at 13,000 rpm for 15 min, and the supernatant was analyzed by SDS-PAGE.
In vivo ϕ29 scaffold complementation direct plaque assay B. subtilis spoA12 su À cells carrying the plasmids of pHCMC05-gp7 mutants and B. subtilis su +44 cells were each grown in 416 media at 37 1C. When cells reached a density of 4 Â 10 8 cells/ml, they were diluted 5 times in fresh 416 medium and grown another cycle to reach exponential phase (4 Â 10 8 cells/ml). A 0.3 ml aliquot of cells was added to 2.0 ml of 416 top agar, which was supplemented with chloramphenicol and 0.1 ml of either wild type or amber gp7 ϕ29 viral stocks with and without 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The mixture was plated on 25 ml LB plates and incubated overnight at 37 1C.
In vivo ϕ29 scaffold complementation assay B. subtilis spoA12 su À cells carrying the plasmids of pHCMC05-gp7 mutants and su +44 cells were each grown as described above.
Once cells reached exponential phase, an aliquot was supplemented with IPTG to pre-induce expression of the respective Connector (gp10) Fig. 6 . Biochemical analysis of particles synthesized in null-gp7 infected cells. Each sucrose gradient was prepared as described in Materials and Methods and separated into approximately 40 fractions. Every other fraction was analyzed by SDS-PAGE and Western blot, utilizing antibodies recognizing the coat and head fiber proteins (top panels), as well as the connector protein (bottom panels). Only the relevant fractions are depicted in the figure. Virion, procapsids, particles and proteins from null-gp7 infections were generated in B. subtilis su+44 or spoA12 su-non-suppressor cells harboring plasmids expressing the indicated scaffolding (gp7) gene (A) su+44 suppressor strain (no plasmid); (B) B. WT; (C) K66A; (D) E56K; (E) R69E; (F). spoA12 su-cells (no plasmid).
scaffolding gene and infected with the indicated viral strain at a multiplicity of infection (MOI) ¼0.1. At each ten minute time point, over the course of two hours, 0.1 ml of the infected culture was removed and plated on lawns of su +44 cells to obtain the titer and spoA12 su À cells to ensure the retention of the amber phenotype.
The plates incubated overnight at 37 1C.
Detection of virion, procapsids and assembled particles from infected cells B. subtilis spoA12 su À cells carrying the plasmids of pHCMC05-gp7 mutants and su +44 cells were each grown as described above.
Cells at were harvested and subjected to centrifugation at 5000 rpm for 10 min at room temperature, then resuspended in 416 media and concentrated to 2 Â 10 9 cells/ml.
The concentrated cells were infected with the amber gp7 ϕ29 strain at a multiplicity of infection (MOI) of 10 and shaken for 5 min at room temperature. The mixture was diluted 10 times with 416 media with or without IPTG (0.5 mM), incubated at 37 1C for 2 h and shaken at 200 rpm. The cells were lysed with egg white lysozyme (20 mg/ml) and DNase I (5 mg/ml). Cell debris was clarified by centrifugation (5000 rpm) for 30 min at room temperature. The supernatant was then used to obtain phage titers and isolated particles.
The supernatant obtained above was sedimented at 40,000 rpm for 1 h in a Beckman Ti 42.1 rotor; the pellet was resuspended in 0.5 ml TMS buffer and allowed to shake overnight at 4 1C. The resuspension was loaded onto a CsCl density gradient of 1.3-1.7 g/ cm 3 in a buffer of 50 mM Tris (pH 7.6),100 mM MgCl 2 and centrifuged at 38,000 rpm for 2 h in a Beckman SW41 Ti rotor and fractionated to isolate procapsids, virion and aberrant structures. The relevant fractions were stained by 2% uranyl acetate and observed under the transmission electron microscope. The same resupension was also loaded onto a 5-30% sucrose gradient, centrifuged with a SW55 rotor at 41,000 rpm for 50 min at 4 1C and fractionated. The fractions were analyzed by SDS-PAGE, and the presence or absence of connector protein was determined through Western Blot with anti-connector antibodies.
